Aeromonas hydrophila in Aquaculture: An Emerging Pathogen in Fish

Introduction

Aeromonas hydrophila is a Gram-negative, facultatively anaerobic, rod-shaped bacterium belonging to the family Aeromonadaceae. It is a ubiquitous inhabitant of aquatic environments, including freshwater and brackish water systems, and is recognized as a primary and opportunistic pathogen of a wide range of fish species in aquaculture settings worldwide. The emergence of A. hydrophila as a significant threat to global aquaculture production is driven by its broad host range, the severity of its clinical manifestations, and the increasing prevalence of antimicrobial resistance (AMR) among isolates. This article provides a detailed examination of the pathogen's biology, clinical disease presentation, diagnostic approaches, AMR mechanisms, and biosecurity strategies, with a focus on recent advances in molecular characterization and disease management.

Taxonomy and Pathogen Characteristics

Aeromonas hydrophila is classified within the genus Aeromonas, which comprises over 30 species. The species is further divided into subspecies, including A. hydrophila subsp. hydrophila and A. hydrophila subsp. ranae. The bacterium is motile via a single polar flagellum, although lateral flagella may be expressed under specific conditions. It is oxidase-positive, catalase-positive, and capable of fermenting glucose with acid production. Optimal growth occurs at temperatures between 25 degrees Celsius and 30 degrees Celsius, though the organism can proliferate across a broader range, which is relevant to seasonal disease outbreaks in aquaculture.

The pathogenicity of A. hydrophila is multifactorial, involving a suite of virulence factors. Key determinants include the pore-forming toxin aerolysin, which causes cytolytic damage to host cells, and various hemolysins. The type II secretion system (T2SS) and type III secretion system (T3SS) are critical for the export of these toxins and other effector proteins directly into host cells. Additionally, the bacterium produces proteases, lipases, and nucleases that contribute to tissue degradation and immune evasion. Quorum sensing (QS) mechanisms, mediated by N-acyl homoserine lactones (AHLs), regulate the expression of many virulence genes in a cell-density-dependent manner [1]. The ability to form biofilms on both biotic and abiotic surfaces further enhances persistence in aquaculture systems and resistance to disinfectants.

Clinical Signs and Pathogenesis

The primary clinical syndrome associated with A. hydrophila infection in fish is hemorrhagic septicemia. This condition is characterized by a systemic infection that leads to widespread vascular damage and hemorrhage. Clinical signs vary depending on fish species, age, immune status, and environmental stressors such as elevated temperature, poor water quality, and overcrowding.

External Clinical Signs

External manifestations include focal to diffuse hemorrhages on the skin, fins, opercula, and around the vent. Exophthalmos (pop-eye) with or without corneal opacity is frequently observed. Cutaneous ulcers, which may progress to deep necrotic lesions, are common in chronic or subacute cases. Affected fish often exhibit lethargy, anorexia, erratic swimming, and loss of equilibrium. In severe outbreaks, mortality can reach 80 to 100 percent within a short period.

Internal Pathology

Necropsy findings typically reveal petechial and ecchymotic hemorrhages on the serosal surfaces of internal organs, including the liver, spleen, kidney, and swim bladder. The liver may appear pale, friable, or mottled. The spleen and kidney are often enlarged and congested. Ascitic fluid accumulation in the peritoneal cavity is a frequent finding. Histopathological examination shows extensive necrosis of hepatocytes, renal tubular epithelium, and splenic tissue. The gills may exhibit lamellar congestion, edema, and epithelial lifting, contributing to respiratory distress.

Pathophysiological Mechanisms

The pathogenesis of hemorrhagic septicemia begins with bacterial adhesion to host epithelial surfaces, facilitated by pili and outer membrane proteins. Following colonization, A. hydrophila invades the host through the gills, skin, or gastrointestinal tract. Once in the bloodstream, the bacterium proliferates and disseminates to internal organs. Aerolysin and hemolysins cause direct lysis of erythrocytes and endothelial cells, leading to increased vascular permeability and hemorrhage. The T3SS injects effector proteins that disrupt host cell signaling and induce apoptosis. The host inflammatory response, while intended to control infection, contributes to tissue damage through the release of reactive oxygen species and pro-inflammatory cytokines. Recent transcriptomic studies in channel catfish (Ictalurus punctatus) have revealed complex immuno-metabolic interactions following A. hydrophila infection, highlighting the role of hepatic metabolic reprogramming in the disease outcome [2].

Diagnostic Approaches

Accurate and timely diagnosis of A. hydrophila infection is essential for effective disease management. Diagnostic methods range from conventional culture and biochemical identification to advanced molecular and immunological techniques.

Conventional Bacteriology

Isolation of A. hydrophila from infected tissues (kidney, spleen, liver, or blood) is performed on general-purpose media such as tryptic soy agar (TSA) or brain heart infusion agar (BHIA). Selective media, including Rimler-Shotts agar and Aeromonas selective agar, are used to suppress competing flora. Colonies are typically round, smooth, and cream-colored. Biochemical identification relies on a panel of tests: oxidase positive, catalase positive, glucose fermentation, esculin hydrolysis, and resistance to the vibriostatic agent O/129. However, phenotypic identification can be ambiguous due to variability within the species.

Molecular Diagnostics

Molecular methods offer superior sensitivity and specificity. Polymerase chain reaction (PCR) assays targeting the 16S rRNA gene, the aerolysin gene (aerA), or the hemolysin gene (hlyA) are widely used for species-level identification and virulence profiling. Real-time quantitative PCR (qPCR) allows for quantification of bacterial load in tissues and water samples. Isothermal amplification techniques, such as recombinase polymerase amplification (RPA), have been developed for rapid, field-deployable detection of aquatic bacterial pathogens, including A. hydrophila [3]. These methods are particularly valuable in resource-limited settings where thermocyclers are unavailable.

Serological and Immunological Methods

Enzyme-linked immunosorbent assays (ELISAs) using monoclonal or polyclonal antibodies against surface antigens (e.g., lipopolysaccharide, outer membrane proteins) can detect A. hydrophila in fish tissues and water samples. The development of recombinant proteins, such as the maltose-inducible porin LamB, has enabled the generation of cross-species agglutinating antibodies for diagnostic and vaccine applications [4]. Lateral flow immunoassays represent a potential point-of-care diagnostic tool, though their commercial availability for A. hydrophila remains limited.

Antimicrobial Susceptibility Testing

Given the high prevalence of AMR, antimicrobial susceptibility testing (AST) is a critical component of the diagnostic workup. Disk diffusion and broth microdilution methods are performed according to standardized guidelines (e.g., Clinical and Laboratory Standards Institute, CLSI). Minimum inhibitory concentration (MIC) values are determined for a panel of antibiotics commonly used in aquaculture, including oxytetracycline, florfenicol, enrofloxacin, and sulfonamides. Results guide the selection of appropriate therapeutic agents and inform surveillance of resistance trends.

Antimicrobial Resistance Patterns

The widespread and often prophylactic use of antibiotics in aquaculture has driven the emergence and dissemination of AMR in A. hydrophila populations. Resistance has been reported to multiple antibiotic classes, including tetracyclines, quinolones, phenicols, and beta-lactams.

Mechanisms of Resistance

Resistance mechanisms in A. hydrophila include enzymatic inactivation of antibiotics, target site modification, reduced membrane permeability, and active efflux. Beta-lactamase production, particularly of class A, C, and D beta-lactamases, confers resistance to penicillins and cephalosporins. Tetracycline resistance is commonly mediated by ribosomal protection proteins (e.g., TetM, TetO) or efflux pumps (e.g., TetA, TetB). Quinolone resistance is associated with mutations in the DNA gyrase genes (gyrA, gyrB) and topoisomerase IV genes (parC, parE), as well as plasmid-mediated quinolone resistance (PMQR) determinants such as qnr genes. The acquisition of resistance genes via horizontal gene transfer, facilitated by plasmids, integrons, and transposons, is a major driver of multidrug resistance (MDR).

Impact of Subtherapeutic Antibiotic Exposure

Subtherapeutic levels of antibiotics in aquaculture systems exert selective pressure that promotes the development of resistance. A study examining the effect of subtherapeutic oxytetracycline exposure demonstrated a significant increase in the frequency of resistant A. hydrophila isolates and the upregulation of resistance-associated genes [5]. This finding underscores the risk associated with the routine use of antibiotics as growth promoters or prophylactic agents.

Surveillance and Stewardship

Systematic surveillance of AMR in A. hydrophila is necessary to monitor resistance trends and inform treatment guidelines. A stage-aligned disease management framework has been proposed to integrate AMR stewardship into aquaculture practices, emphasizing the importance of accurate diagnosis, targeted therapy, and the reduction of unnecessary antibiotic use [6]. This framework aligns with broader One Health initiatives addressing AMR across human, animal, and environmental sectors.

Biosecurity Measures

Effective biosecurity is the cornerstone of preventing and controlling A. hydrophila outbreaks in aquaculture. Biosecurity encompasses a set of management practices designed to reduce the introduction and spread of pathogens within and between production units.

Facility Design and Management

Physical barriers, such as fencing and covered tanks, prevent contact with wild fish and other potential carriers. Dedicated equipment and footwear for each production unit, along with footbaths containing disinfectants, minimize mechanical transmission. Water source management is critical; surface water should be treated (e.g., by filtration, ultraviolet irradiation, or ozonation) before entering the facility. Effluent treatment systems prevent the discharge of pathogens into the environment.

Disinfection Protocols

The efficacy of disinfectants against A. hydrophila is influenced by temperature, organic load, and bacterial innate properties [7]. Common disinfectants used in aquaculture include chlorine compounds, iodophors, hydrogen peroxide, and quaternary ammonium compounds. Disinfection of nets, tanks, and other equipment should be performed routinely and after any disease event. The concentration and contact time must be optimized for the specific disinfectant and conditions.

Stock Management and Quarantine

Introduction of new fish stocks represents a major risk for pathogen introduction. All incoming fish should be sourced from certified disease-free facilities and subjected to a quarantine period of at least 2 to 4 weeks. During quarantine, fish should be monitored for clinical signs and, if possible, screened for A. hydrophila using molecular methods. Vaccination, where available, can be administered during this period.

Water Quality Management

Maintaining optimal water quality parameters reduces stress and enhances the innate immune response of fish. Key parameters include dissolved oxygen (above 5 mg/L), temperature (species-specific optimal range), pH (6.5 to 8.5), and ammonia and nitrite levels (below toxic thresholds). Regular monitoring and correction of these parameters are essential. Biofilm management in water distribution systems also reduces the reservoir of A. hydrophila.

Nutritional Interventions and Immunostimulants

Dietary supplementation with immunostimulants and functional feeds has shown promise in enhancing resistance to A. hydrophila. Sodium butyrate supplementation improved growth performance, gut health, and disease resistance in Labeo rohita [8]. Similarly, the co-administration of recombinant Pichia pastoris expressing CXCL20a and immunostimulatory polysaccharides enhanced resistance in grass carp (Ctenopharyngodon idella) [9]. Organic acids have been shown to target key virulence factors of A. hydrophila, reducing infection in vitro [10]. These nutritional strategies offer alternatives to antibiotic use and can be integrated into a comprehensive health management plan.

Vaccination Strategies

Vaccination is a key tool for specific prophylaxis against A. hydrophila. Both inactivated (killed) and live attenuated vaccines have been developed. Recombinant subunit vaccines targeting virulence factors, such as the type IVc pilus protein TadZ, have induced protective immunity in channel catfish [11]. Engineered probiotics, such as Bacillus subtilis secreting antimicrobial peptides (piscidin-1/hepcidin), have also demonstrated efficacy in a zebrafish model [12]. The development of effective, multivalent vaccines that provide cross-protection against multiple Aeromonas species remains an active area of research.

Disease Management Framework

A structured, stage-aligned approach to disease management facilitates timely intervention and reduces the impact of outbreaks. The following Mermaid diagram illustrates a decision tree for managing A. hydrophila infections in aquaculture.

graph TD
    A[Clinical Signs Observed], > B{Immediate Assessment}
    B, > C[Water Quality Check]
    B, > D[Clinical Examination]
    C, > E[Correct Water Quality Parameters]
    D, > F[Sample Collection for Diagnostics]
    F, > G[Laboratory Confirmation]
    G, > H{Pathogen Identified?}
    H, >|Yes| I[Antimicrobial Susceptibility Testing]
    H, >|No| J[Rule Out Other Pathogens]
    I, > K[Select Targeted Antibiotic]
    K, > L[Treatment Administration]
    L, > M[Monitor Response]
    M, > N{Clinical Improvement?}
    N, >|Yes| O[Continue Treatment & Biosecurity]
    N, >|No| P[Re-evaluate Diagnosis & AST]
    P, > Q[Consider Alternative Therapy]
    O, > R[Post-Outbreak Disinfection]
    R, > S[Restock with Certified Disease-Free Stock]
    S, > T[Enhanced Surveillance]

This framework emphasizes the importance of rapid diagnosis, targeted therapy based on AST results, and rigorous biosecurity to prevent recurrence.

Conclusion

Aeromonas hydrophila represents a significant and emerging threat to global aquaculture, causing severe economic losses through hemorrhagic septicemia outbreaks. The pathogen's complex virulence repertoire, coupled with its capacity to acquire and disseminate antimicrobial resistance genes, necessitates a multifaceted approach to disease management. Advances in molecular diagnostics, including isothermal amplification and recombinant antigen-based serology, are improving the speed and accuracy of detection. The development of effective vaccines and immunostimulatory feed additives offers promising alternatives to antibiotic therapy. However, the cornerstone of disease control remains robust biosecurity practices, including water quality management, disinfection protocols, and quarantine procedures. A stage-aligned disease management framework that integrates diagnostics, antimicrobial stewardship, and preventive measures is essential for sustainable aquaculture production. Continued research into the molecular mechanisms of pathogenesis, host immune responses, and AMR evolution will inform future control strategies.

References

[1] Li S, Ma X, Zhou S, et al. Apigenin decreases the pathogenicity of Aeromonas hydrophila infection by inhibiting aerolysin activity and interfering with quorum sensing. J Appl Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42233888/

[2] Soku YK, Lange MD, Abernathy JW, et al. Hepatic transcriptomics reveals immuno-metabolic interactions in juvenile channel catfish (Ictalurus punctatus) after Aeromonas hydrophila infection. BMC Genomics. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42210080/

[3] Luo H, Wu Z, Fan W, et al. Establishment of methods for visual and rapid detection of piscine lactococcosis based on isothermal recombinase polymerase amplification. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42210273/

[4] Upadhyaya T, Yadav SK, Sharma V, et al. Recombinant maltose-inducible porin LamB of Aeromonas hydrophila induces T(H)2-biased mixed immune response and generates cross-species agglutinating antibodies in the murine model. Mol Biol Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42183925/

[5] Zhang J, Huang L, Zhong L, et al. Antibiotic resistance in Aeromonas hydrophila associated with exposure to subtherapeutic levels of oxytetracycline. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42182037/

[6] Hamid NH, Karim MMA, Daud HM, et al. A Stage-Aligned Disease Management Framework for Aeromonas hydrophila in Aquaculture: Implications for Antimicrobial Stewardship. J Fish Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42163554/

[7] Adibe AC, Crumlish M. Temperature, Disinfectant Concentration and Bacterial Innate Properties Influence the Disinfection of Bacterial Pathogens Relevant to Catfish Aquaculture. J Fish Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42218302/

[8] Younas A, Fatima M, Shah SZH, et al. Sodium butyrate supplementation improves growth performance, gut health, hepatic enzyme activities, and disease resistance against Aeromonas hydrophila in Labeo rohita. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42240874/

[9] Li W, Lv M, Chen G, et al. Co-administration of recombinant Pichia pastoris-CXCL20a and immunostimulatory polysaccharides enhances resistance to Aeromonas hydrophila in grass carp (Ctenopharyngodon idella). Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42229674/

[10] Morariu F, Balta I, Stef L, et al. Organic acids target key virulence factors of Aeromonas hydrophila to reduce infection in vitro. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42205576/

[11] Park YK, Patel F, Abdelhamed H, et al. Recombinant TadZ from the type IVc pilus system induces protective immunity against virulent Aeromonas hydrophila in channel catfish (Ictalurus punctatus). Front Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42183290/

[12] Zhang KY, Zhang WY, Liu JX, et al. Engineered Bacillus subtilis secreting piscidin-1/hepcidin enhances resistance against Aeromonas hydrophila in a zebrafish model. Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42176787/

[13] Xu J, Liu T, Chen J, et al. Luteolin protects crucian carp against Aeromonas hydrophila by modulating inflammation-apoptosis axis. Dev Comp Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42242402/

[14] Shehata AI, El Basuini MF, Shija VM, et al. Combined and interactive impacts of octacosanol and Saccharomyces cerevisiae on growth, physiological responses, and disease resistance in whiteleg shrimp (Litopenaeus vannamei). Dev Comp Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42203038/

[15] Wei Q, Yuan Y, Wei M, et al. Mechanistic insights of the bactericidal effects of plasma-activated tryptophan water on Aeromonas hydrophila and Shewanella putrefaciens. Food Res Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169347/